BioNTech公布BNT113联合帕博利珠单抗治疗转移性HPV16阳性头颈癌的2/3期临床试验更新

原文标题：BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer